0001209191-21-028189.txt : 20210423
0001209191-21-028189.hdr.sgml : 20210423
20210423192702
ACCESSION NUMBER: 0001209191-21-028189
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210421
FILED AS OF DATE: 20210423
DATE AS OF CHANGE: 20210423
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Garfield Greg Shaw
CENTRAL INDEX KEY: 0001594406
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40337
FILM NUMBER: 21851090
MAIL ADDRESS:
STREET 1: C/O SEMLER SCIENTIFIC, INC.
STREET 2: 2330 NW EVERETT ST.
CITY: PORTLAND
STATE: OR
ZIP: 97210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeuroPace Inc
CENTRAL INDEX KEY: 0001528287
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 223550230
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 455 N. BERNARDO AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 6502372700
MAIL ADDRESS:
STREET 1: 455 N. BERNARDO AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-21
0
0001528287
NeuroPace Inc
NPCE
0001594406
Garfield Greg Shaw
368 EAST CAMPBELL AVENUE
SUITE 200
CAMPBELL
CA
95008
1
0
0
0
Common Stock
2021-04-21
4
P
0
13235
17.00
A
38853
D
Stock Option (Right to Buy)
17.00
2021-04-21
4
A
0
21698
0.00
A
2031-04-20
Common Stock
21698
21698
D
Reflects shares purchased from the underwriters in the Companys initial public offering.
1/36th of the shares subject to the option vest in equal monthly installments commencing May 21, 2021.
/s/ Mark B. Weeks, Attorney-in-Fact
2021-04-23